Evofem Biosciences, Inc. Skyrocketed
Fri, Aug 25, 2023 at 07:10 PM
Evofem Biosciences, Inc. (EVFM:NASDAQ) soared at $0.2, a gain of 33.3%. On Fri, Aug 25, 2023, EVFM:NASDAQ hit a New 2-Week Intraday Low of $0.14. The stock appeared on our News Catalysts scanner on Tue, Aug 22, 2023 at 06:12 PM in the 'AGREEMENT' category. From Fri, Aug 11, 2023, the stock recorded 30.00% Up Days and 18.18% Green Days
About Evofem Biosciences, Inc. (EVFM:NASDAQ)
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Top 10 Gainers:
- YS Biopharma Co. Ltd. (YS:NASDAQ), 65.56%
- Cano Health Inc. Class A (CANO:NYSE), 41.3%
- VinFast Auto Ltd. (VFS:NASDAQ), 40.35%
- Alset Capital Acquisition Corp. (ACAX:NASDAQ), 39.46%
- Chanson International Holding (CHSN:NASDAQ), 33.94%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 33.33%
- Akso Health Group (AHG:NASDAQ), 31.63%
- BitNile Metaverse Inc Com (New) (BNMV:NASDAQ), 29.86%
- Genius Group Limited (GNS:NYSEMKT), 29.2%
- Affirm Holdings Inc. (AFRM:NASDAQ), 28.82%